Found 19 matching trials
Reduced-Dose Chemo Followed by 14 Days of Blinatumomab for Newly Diagnosed Adult B-ALL Patients: a Multicenter Study N/A This is a prospective, multicenter, observational study aimed at exploring ...
Show More Location
Multiple Locations
Learn More & Join Trial
Blinatumomab Intensification for MRD-Negative Acute B-Cell Lymphoblastic Leukemia Before Allogeneic Hematopoietic Stem Cell Transplantation NA This is a prospective, multicenter, randomized controlled trial designed to...
Show More Location
The First Affiliated Hospital of Zhejiang University School of Medicine
Learn More & Join Trial
Prospective, Single-arm, Multicenter Clinical Study on Haploidentical Hematopoietic Stem Cell Transplantation in Patients With MRD Positive CD19+ALL Treated With Conditioning Regimens Containing Blinatumomab PHASE1 A study on the effectiveness and safety of haploidentical hematopoietic ste...
Show More Location
The first affiliated hospital of medical college of zhejiang university
Learn More & Join Trial
Safety and Efficacy of BiTE in Desensitization Therapy for Highly Sensitized Kidney Transplant Candidates With cPRA ≥ 90% PHASE4 This study is a prospective, open-label, two-arm exploratory clinical trial...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Blinatumomab in Japanese Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia PHASE1 This is an open-label, combined 2-part multicenter study to evaluate the ef...
Show More Location
National Hospital Organization Nagoya Medical Center
Learn More & Join Trial
Safety and Efficacy of the Bispecific T-Cell Engager (BiTE) as Conditioning Regimen for ABO-incompatible Living Donor Kidney Transplantation EARLY_PHASE1 The goal of this clinical trial was to determine whether the Bites drugs (B...
Show More Location
Multiple Locations
Learn More & Join Trial
Study Evaluating the Efficacy of 90Yttrium-epratuzumab in Adults With CD22+ Relapsed/Refractory B-ALL PHASE2 The investigators propose a randomized phase 2 study evaluating 90Y-epratuz...
Show More Location
CHU de Clermont-Ferrand
Learn More & Join Trial
Blinatumomab in Refractory Myasthenia Gravis (BLINA-MG) PHASE2 The goal of this clinical trial is to evaluating the efficacy and safety of...
Show More Location
Multiple Locations
Learn More & Join Trial
NGS MRD-Guided Blinatumomab Treatment for Pediatric B-ALL NA The goal of this clinical trial is to determine whether pediatric B-cell ac...
Show More Location
Multiple Locations
Learn More & Join Trial
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020) PHASE3 The IntReALL BCP 2020 study aims to review recent developments and findings...
Show More Location
St. Anna Kinderspital GmbH
Learn More & Join Trial